Danaher Corp(DHR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 6:20 PM ET (Korea 10/28 07:20)
Full metrics table
| Index | S&P 500 | P/E | 37.99 | EPS (ttm) | 6.11 | Insider Own | 8.98% | Shs Outstand | 703.4M | Perf Week | 3.46% |
| Market Cap | 163.22B | Forward P/E | 24.92 | EPS next Y | 8.46% | Insider Trans | -0.09% | Shs Float | 640.4M | Perf Month | 2.05% |
| Enterprise Value | 185.33B | PEG | 2.63 | EPS next Q | 2.48 | Inst Own | 84.44% | Short Float | 1.27% | Perf Quarter | 18.07% |
| Income | 4.33B | P/S | 6.37 | EPS this Y | 10.04% | Inst Trans | -1.08% | Short Ratio | 1.91 | Perf Half Y | 29.62% |
| Sales | 25.61B | P/B | 3.04 | EPS next 5Y | 9.48% | ROA | 4.95% | Short Interest | 8.14M | Perf YTD | 1.35% |
| Book/sh | 76.23 | P/C | 28.73 | EPS past 3/5Y | -19.39% 0.65% | ROE | 8.19% | 52W High | -4.45% ($242.80) | Perf Year | 4.97% |
| Cash/sh | 8.08 | P/FCF | 28.5 | Sales past 3/5Y | -2.67% 1.97% | ROIC | 5.55% | 52W Low | 44.16% ($160.93) | Perf 3Y | 23.48% |
| Dividend Est. | $1.44 (0.62%) | EV/EBITDA | 23.19 | EPS Y/Y TTM | 25.53% | Gross Margin | 58.85% | Volatility(W/M) | 3.62% 3.07% | Perf 5Y | -14.25% |
| Dividend TTM | 1.52 | EV/Sales | 7.24 | Sales Y/Y TTM | 5.52% | Oper. Margin | 20.94% | ATR (14) | 6.53 | Perf 10Y | 234.14% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 1.29 | EPS Q/Q | 37.34% | Profit Margin | 16.91% | RSI (14) | 60.63 | Recom | 1.5 |
| Dividend Gr. 3/5Y | 8.58% 12.2% | Current Ratio | 1.63 | Sales Q/Q | 8.28% | SMA20 | 3.64% ($223.85) | Beta | 0.78 | Target Price | $259.95 |
| Payout | 25.36% | Debt/Eq | 0.52 | Earnings | 2026/10/21 | SMA50 | 6.75% ($217.33) | Rel Volume | 0.59 | Prev Close | $232.97 |
| Employees | 60000 | LT Debt/Eq | 0.45 | EPS/Sales Surpr. | 10.05% -0.09% | SMA200 | 15.33% ($201.16) | Avg Volume(3M) | 4.27M | Price | $232 |
| IPO | 1969/12/10 | Option/Short | Yes/Yes | Trades | 29519 | Volume | 2,497,798 | Change | -0.42% |
🔬 This is a global healthcare tools and diagnostics group covering bioprocessing, diagnostics, and life sciences instruments. Headquartered in Washington, D.C., the group traces its roots back to 1969 and has built a diversified diagnostics and life sciences portfolio through an acquisition- and repositioning-driven operating model.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded less than usual. That is 59% of its average volume.
DHR earns at a steady pace
Of every $100 in sales, $20.94 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.0% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $2,319. Peers typically go for $2,642. Compared with its own 5-year average, it is 26% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -14.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.62% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 84.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 44 in the industry
Based on market cap of $163B.
FAQ
What kind of company is DHR?
DHR belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of DHR?
The market cap of DHR is approximately $163.2B, ranking 96 within its sector.
Does DHR pay dividends?
DHR has a dividend yield of approximately 0.62%, with an annual dividend of $1.44.
What is the P/E ratio of DHR?
DHR has a P/E ratio of approximately 38.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DHR?
DHR has recorded a 52-week high of $242.80 and a low of $160.93.
